Search here to find large public and licensed datasets
Action to Control Cardiovascular Risk in Diabetes Trial
ACCORD was a large clinical trial examining methods of lowering the rate of cardiovascular disease in adults with type two diabetes. The study was composed of three clinical trials: an intensive lowering of blood sugar levels, intensive lowering of blood pressure, and treatment of multiple blood lipids with a combination of a fibrate and a statin. The study enrolled 10,251 adults beginning in 2001.
Researchers can apply to use ACCORD data through BioLINCC at https://biolincc.nhlbi.nih.gov/requests/type/accord/ (registration required). According to the ACCORD Study Protocol, all ancillary studies must be reviewed and approved to access data. An ACCORD principal investigator or co-investigator must be included as the PI or co-investigator on an ancillary study. Studies should allow at least 60 days before a funding application deadline to assure timely approval.